IT1187833B - Procedimento per l ottenimento di polidesossiribonucleotidi non informazionali sostanzialmente puri e dotati di attivita biologiche e prodotto relativo - Google Patents

Procedimento per l ottenimento di polidesossiribonucleotidi non informazionali sostanzialmente puri e dotati di attivita biologiche e prodotto relativo

Info

Publication number
IT1187833B
IT1187833B IT8568074A IT6807485A IT1187833B IT 1187833 B IT1187833 B IT 1187833B IT 8568074 A IT8568074 A IT 8568074A IT 6807485 A IT6807485 A IT 6807485A IT 1187833 B IT1187833 B IT 1187833B
Authority
IT
Italy
Prior art keywords
pdrn
informational
inhibition
sepn
liq
Prior art date
Application number
IT8568074A
Other languages
English (en)
Other versions
IT8568074A0 (it
Inventor
Pietro Bianchini
Original Assignee
Farmigea Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11307651&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1187833(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Farmigea Spa filed Critical Farmigea Spa
Priority to IT8568074A priority Critical patent/IT1187833B/it
Publication of IT8568074A0 publication Critical patent/IT8568074A0/it
Priority to ES86202241T priority patent/ES2048142T3/es
Priority to EP86202241A priority patent/EP0226254B1/en
Priority to AT86202241T priority patent/ATE98252T1/de
Priority to DE3689375T priority patent/DE3689375T2/de
Priority to JP61300193A priority patent/JPS62155293A/ja
Application granted granted Critical
Publication of IT1187833B publication Critical patent/IT1187833B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT8568074A 1985-12-12 1985-12-12 Procedimento per l ottenimento di polidesossiribonucleotidi non informazionali sostanzialmente puri e dotati di attivita biologiche e prodotto relativo IT1187833B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT8568074A IT1187833B (it) 1985-12-12 1985-12-12 Procedimento per l ottenimento di polidesossiribonucleotidi non informazionali sostanzialmente puri e dotati di attivita biologiche e prodotto relativo
ES86202241T ES2048142T3 (es) 1985-12-12 1986-12-11 Procedimiento de obtencion de polidesoxirribonucleotidos sustancialmente puros y no informacionales que tienen actividades biologicas, y producto respectivo.
EP86202241A EP0226254B1 (en) 1985-12-12 1986-12-11 Process for obtaining non informational substantially pure polydesoxyribonucleotides having biologic activities, and respective product
AT86202241T ATE98252T1 (de) 1985-12-12 1986-12-11 Verfahren zur herstellung von substantiell reinen nicht fuer transpiration geeigneten polydesoxyribonukleotiden mit biologischen aktivitaeten und respektives produkt.
DE3689375T DE3689375T2 (de) 1985-12-12 1986-12-11 Verfahren zur Herstellung von substantiell reinen nicht für Transpiration geeigneten Polydesoxyribonukleotiden mit biologischen Aktivitäten und respektives Produkt.
JP61300193A JPS62155293A (ja) 1985-12-12 1986-12-18 生物活性を有する実質的に純粋な非情報的ポリデオキシリボヌクレオチドおよびその生産方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8568074A IT1187833B (it) 1985-12-12 1985-12-12 Procedimento per l ottenimento di polidesossiribonucleotidi non informazionali sostanzialmente puri e dotati di attivita biologiche e prodotto relativo

Publications (2)

Publication Number Publication Date
IT8568074A0 IT8568074A0 (it) 1985-12-19
IT1187833B true IT1187833B (it) 1987-12-23

Family

ID=11307651

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8568074A IT1187833B (it) 1985-12-12 1985-12-12 Procedimento per l ottenimento di polidesossiribonucleotidi non informazionali sostanzialmente puri e dotati di attivita biologiche e prodotto relativo

Country Status (6)

Country Link
EP (1) EP0226254B1 (it)
JP (1) JPS62155293A (it)
AT (1) ATE98252T1 (it)
DE (1) DE3689375T2 (it)
ES (1) ES2048142T3 (it)
IT (1) IT1187833B (it)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20090485A1 (it) * 2009-09-23 2011-03-24 Nicola Valerio Di Composizione comprendente un componente ematico e suo uso per il trattamento delle malattie degenerative articolari
ITRM20100295A1 (it) * 2010-06-01 2011-12-02 Nicola Valerio Di Composizione comprendente un componente ematico e suo uso per il trattamento delle malattie degenerative articolari

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1297431C (en) * 1987-04-24 1992-03-17 F. Hoffmann-La Roche Ag Process for the isolation of nucleic acids
EP0338591A3 (en) * 1988-04-21 1991-09-04 Microprobe Corporation Nucleic acid extraction method
IT1391866B1 (it) 2008-10-30 2012-01-27 Mastelli S R L Composizione iniettabile di polinucleotidi per il trattamento di patologie osteoarticolari.
EP2480239A1 (en) * 2009-09-23 2012-08-01 Valerio Di Nicola Composition comprising a haematic component and its use for the treatment of degenerative joint disease
IT1401218B1 (it) * 2010-07-14 2013-07-12 Mastelli S R L Composizione ad attivita' bio-rigenerativa, riparativa ed eutrofizzante.
IT1406068B1 (it) 2010-07-22 2014-02-06 Medestea Int Spa Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
ITUB20155754A1 (it) * 2015-11-20 2017-05-20 Mastelli S R L Composizione per il trattamento di malattie imfiammatorie intestinali.
KR102234367B1 (ko) * 2020-09-07 2021-03-31 바이오메디팜 어업회사법인 주식회사 연어의 정소로부터 고순도 피디알엔의 추출 방법
IT202100001496A1 (it) 2021-01-26 2022-07-26 I R A St Ricerche Applicate S P A Processo per la produzione di un gel a base di polinucleotidi e suo uso nel trattamento di patologie osteoarticolari
CN117396180A (zh) * 2021-06-02 2024-01-12 株式会社Lg生活健康 模拟紫河车的化妆料组合物
CN120484034B (zh) * 2025-07-10 2025-11-28 恒昱生物制药(山东)有限公司 一种多聚脱氧核糖核苷酸灭活工艺及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE620479A (it) *
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
US3899481A (en) * 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
BE780872A (fr) * 1972-03-17 Crinos Industria Farmaco Procede d'extraction de sels alcalins de l'acide desoxyribonucleique a partir d'organes d'animaux.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20090485A1 (it) * 2009-09-23 2011-03-24 Nicola Valerio Di Composizione comprendente un componente ematico e suo uso per il trattamento delle malattie degenerative articolari
ITRM20100295A1 (it) * 2010-06-01 2011-12-02 Nicola Valerio Di Composizione comprendente un componente ematico e suo uso per il trattamento delle malattie degenerative articolari

Also Published As

Publication number Publication date
DE3689375T2 (de) 1994-06-23
ATE98252T1 (de) 1993-12-15
EP0226254A2 (en) 1987-06-24
EP0226254A3 (en) 1988-11-23
IT8568074A0 (it) 1985-12-19
JPS62155293A (ja) 1987-07-10
ES2048142T3 (es) 1994-03-16
DE3689375D1 (de) 1994-01-20
EP0226254B1 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
Burg et al. Cutaneous lymphomas
EP0226254A3 (en) Process for obtaining non informational substantially pure polydesoxyribonucleotides having biologic activities, and respective product.
IT8125424A0 (it) Procedimento per la produzione di alfa -galattosidasi e impieghi dell'enzima cosi' ottenuto.
IT8220662A0 (it) Procedimento per l'ottenimento di mucopolisaccaridi biologicamente attivi, aventi purezza elevata, mediante depolimerizzazione controllata della eparina.
IL138665A0 (en) Peptide factor
CA2104636A1 (en) Use of kallikrein inhibitor for the production of a pharmaceutical for the prophylaxis and therapy of certain diseases
NO924309L (no) Sammensetninger og fremgangsmaater for modulering av rna-aktiviteter gjennom modifikasjon av 5' cap-strukturen til rna
Friedman et al. Modulation of lipoprotein lipase activity in mouse peritoneal macrophages by recombinant human tumor necrosis factor
ATE45992T1 (de) Waermebehandlung von legierungen mit definierter ausdehnung.
Archer The effects of pulsed magnetic fields on bone and cartilage in vitro
EP0595241A3 (de) Nachweis und Inhibierung von Malatenzym in Tumorzellen.
Prasad Effect of sodium butyrate in combination with X0irradiation, chemotherapeutic and cyclic AMP stimulating agents on neuroblastoma cells in culture
Beaudoin et al. Distribution of amylase and chymotrypsin in four regions of the rat pancreas
Andrzejewska et al. The time course of ultrastructural changes in the secretory components of pancreatic acinar cells and trypsinogen activation in taurocholate pancreatitis in rats
IT8921592A0 (it) Stabilizzazione in forma liquida dell'enzima glucosio ossidasi.
Raab Treatment of psoriasis with fumaric acid and fumarates.
Masserano et al. The rapid activation and deactivation of adrenal tyrosine hydroxylase and protein kinase following electroconvulsive shock
MESHII Effect of point defects on mechanical properties of metals[Technical Progress Report, 1 Sep. 1980- 31 Jul. 1981]
Zagulyaeva et al. A Study of Annealing Twins in the Heating of Steel
JPS5388390A (en) Preparation of fibrinolytic solid surface
Pfeiffer Silver is worth gold in technology
GR3015094T3 (en) Tissue plasminogen activator substitution variant.
JPS53142327A (en) Ceramic substrate plating method
陳世煌 A new species of Phoroncidia (Araneae: Theridiidae) from Taiwan
IT8125666A0 (it) Procedimento per la fabbricazione di mobili metallici e mobili cosi'ottenuti.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961230